Tissue Engineering and Regenerative Medicine is Changing the Game

Anna Wynn, Business Development Manager for Instron TERM (Tissue Engineering and Regenerative Medicine) discusses how this science can potentially provide a better quality of life for the population. Instron TERM systems produce 3D tissue comparable to native tissue, which can serve as a substitute or enhancement for tissue impaired by disease, injury, or age.

Read more as Anna reviews common challenges in the field and its growth potential.